EDGAR Filing Documents for 0000950170-23-047761

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0000950170-23-047761

Filing Date

2023-09-12

Accepted

2023-09-12 16:47:42

Documents

110

Period of Report

2023-06-30

Document Format Files

Seq	Description	Document	Type	Size
1	6-K	cntb-20230630.htm iXBRL	6-K	3047781
2	EX-99.1	cntb-ex99_1.htm	EX-99.1	209616
3	GRAPHIC	img219389868_0.jpg	GRAPHIC	9315
	Complete submission text file	0000950170-23-047761.txt		12697259

Data Files

Seq	Description	Document	Type	Size
4	XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT	cntb-20230630.xsd	EX-101.SCH	102687
5	XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT	cntb-20230630_lab.xml	EX-101.LAB	565898
6	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT	cntb-20230630_pre.xml	EX-101.PRE	455014
7	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT	cntb-20230630_def.xml	EX-101.DEF	222774
8	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT	cntb-20230630_cal.xml	EX-101.CAL	78646
104	EXTRACTED XBRL INSTANCE DOCUMENT	cntb-20230630_htm.xml	XML	3067346

Mailing Address 12265 EL CAMINO REAL, SUITE 350 SAN DIEGO CA 92130

Business Address 12265 EL CAMINO REAL, SUITE 350 SAN DIEGO CA 92130 858-727-1040

Connect Biopharma Holdings Ltd (Filer) CIK: 0001835268 (see all company filings)